| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $2.8M | -59.7% |
| SG&A Expense | $9.3M | -4.0% |
| Operating Income | -$17.3M | +20.2% |
| Interest Expense | $100K | — |
| Pre-tax Income | -$18.3M | +7.5% |
| Income Tax | -$1.0M | — |
| Net Income | -$17.3M | +12.6% |
| EPS (Basic) | $0.00 | — |
| EPS (Diluted) | $0.00 | — |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $0 | -100.0% |
| Current Assets | $5.5M | +85.0% |
| Total Assets | $47.9M | -5.3% |
| Current Liabilities | $12.4M | -38.0% |
| Total Liabilities | $19.6M | -30.9% |
| Stockholders' Equity | $28.3M | +27.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$10.6M | +15.8% |
| Investing Cash Flow | $382K | +0.0% |
| Financing Cash Flow | $13.2M | +19.9% |